Abstract #2455

Evaluate the efficiency of the ESWAN value for differentiating renal clear cell carcinoma with different pathological grades.

Xinmiao Bu¹, Ailian Liu¹, Dahua Cui¹, Xin Li², and Qingwei Song¹

¹The First Affiliated Hospital of Dalian Medical University, dalian, China, ²GE Healthcare, Beijing, China

To investigate the potential of ESWAN in differentiating renal clear cell carcinoma with different pathological grades, to help preoperative non-invasive prediction of renal clear cell carcinoma pathological grading.

This abstract and the presentation materials are available to members only; a login is required.

Join Here